Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLZR:a potential 10 bagger? -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (235)	12/30/1999 11:49:00 AM
From: Bruce A. Brotnov	Read Replies (1) \| Respond to of 315

It has been hard to imagine why CLZR at PE of 12 is so overlooked in a sector with PE of 41. Especially hard to explain was the stock pulling back after those last blow out earnings. Besides owning it my self I have it in 2 of my 3 models. I have a rating system of max 12 points (target buys have at least a rating of 6 in most cases) and CLZR has a rating of 8 (max currently in database of 110 stocks is rating of 10 for HOTT and ZOMX). Looks like some profit taking in it today after the nice run yesterday. It was first put in the model at $10. and the $1M model started on 1 September and CLZR was the first one in it at $14. So if someone thinks I was putting it down, then I have been misread. Personally, I like to hear both sides of a stock - positive and negative. In your research do you have an explanation for why it pulled back after earnings? I don't. Thanks for your note. Bruce